Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pregablin for Anxiety-comorbidity in Patients With Schizophrenia - a Double-blinded Randomized Placebo Controlled Study

NCT01496690 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT01496690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01496690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pregablin for Anxiety-comorbidity in Patients With Schizophrenia - a Double-blinded Randomized Placebo Controlled Study
Lead sponsor
University of Aarhus
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2012
Completion date
December 31, 2016
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety-comorbidity to schizophrenia, schizophrenia